D
Aion Therapeutic Inc. ANTCF
$0.0052 -$0.0197-79.12%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

07/31/2022 04/30/2022 01/31/2022 10/31/2021 07/31/2021
Net Income 149.15% -148.73% 19.43% -4.94% 85.47%
Total Depreciation and Amortization 230.77% -90.58% -25.00% -2.13% 2.17%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -209.28% 4,267.20% 47.62% 1,045.45% -99.97%
Change in Net Operating Assets -59.46% 17.25% 34.16% 340.77% -213.52%
Cash from Operations -785.87% 111.89% 74.67% 57.13% -28.85%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- 515.20% 37.19% -- --
Cash from Investing -- 515.20% 37.19% 1.97% 84.82%
Total Debt Issued 94.41% -36.50% -67.14% 128.47% --
Total Debt Repaid 60.18% -- -- 100.00% -253.06%
Issuance of Common Stock -- -- -- -100.00% 27.09%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- 100.00% -69.74%
Cash from Financing 1,848.89% -94.94% -67.36% -52.87% 2.41%
Foreign Exchange rate Adjustments 82.86% -1,037.29% -490.00% -135.71% -97.32%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 980.00% 78.26% 87.17% 59.09% -647.16%
Weiss Ratings